147. Parathyroid Hormone Administration and Parathyroid Hormone Type 1 Receptor Activation Accelerate Muscle Differentiation and Muscle Regeneration in Muscular Dystrophy [PDF]
Molecular Therapy, 2014 openaire +1 more source
A novel homozygous inactivating mutation of the calcium-sensing receptor causing familial hypocalciuric hypercalcemia complicated with primary hyperparathyroidism due to parathyroid adenoma: A case report. [PDF]
J Int Med ResTao X, Yin M, Gang X.
europepmc +1 more source
Pathophysiology and Molecular Signalling in Osteoporosis: Linking Risk Factors to Bone Loss. [PDF]
J Cell Mol MedG P +5 more
europepmc +1 more source
Over-expression of parathyroid hormone Type 1 receptor confers an aggressive phenotype in osteosarcomaOsteosarcoma is the most common primary bone malignancy in children and is associated with rapid bone growth. Parathyroid hormone-related peptide (PTHrP) signaling via parathyroid hormone Type 1 receptor (PTHR1) is important for skeletal development and is involved in bone metastases in other tumors.
openaire
Parathyroid hormone enhances appetite and fails to reduce adiposity in ob/ob mice. [PDF]
Pflugers ArchFajol A +6 more
europepmc +1 more source
Endocrine-liver bidirectional regulation: From mechanistic research to multidisciplinary clinical practice. [PDF]
World J GastroenterolWan KR, Qian C, Liu LM.
europepmc +1 more source
Nf2 orchestrates β-arrestin2-biased PTH1R signaling to couple bone mass with skeletal integrity. [PDF]
Proc Natl Acad Sci U S ALiao J +9 more
europepmc +1 more source
First Reported Use of Recombinant Parathyroid Hormone in Kenny-Caffey Syndrome Type 2: A Case Report and Literature Review. [PDF]
DiseasesDjordjevic Milosevic M +11 more
europepmc +1 more source
Total Thyroidectomy for Severe Thyrotoxicosis in a Young Woman: A Case Report. [PDF]
CureusMora Moreno HE +4 more
europepmc +1 more source
Anabolics in Cancer Patients: To Use or Not to Use? [PDF]
Endocrinol Metab (Seoul)Hong AR.
europepmc +1 more source